• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessment of renal pathology and dysfunction in children with Fabry disease.评估法布里病患儿的肾脏病理和功能障碍。
Clin J Am Soc Nephrol. 2010 Feb;5(2):365-70. doi: 10.2215/CJN.08091109. Epub 2010 Jan 7.
2
Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria.患有法布里病且微量白蛋白尿的儿童和青少年的肾活检结果。
Am J Kidney Dis. 2008 May;51(5):767-76. doi: 10.1053/j.ajkd.2007.12.032. Epub 2008 Mar 20.
3
Renal complications of Fabry disease in children.儿童法布瑞病的肾脏并发症。
Pediatr Nephrol. 2013 May;28(5):679-87. doi: 10.1007/s00467-012-2222-9. Epub 2012 Aug 17.
4
Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease.长期酶替代疗法可减少 Fabry 病女性患者的蛋白尿并保护近端肾小管功能。
Nephrol Dial Transplant. 2014 Mar;29(3):619-25. doi: 10.1093/ndt/gft452. Epub 2013 Nov 8.
5
Renal pathological changes in Fabry disease.法布里病的肾脏病理变化。
J Inherit Metab Dis. 2001;24 Suppl 2:66-70; discussion 65. doi: 10.1023/a:1012423924648.
6
New biomarkers defining a novel early stage of Fabry nephropathy: A diagnostic test study.定义法布里肾病新早期阶段的新型生物标志物:一项诊断试验研究。
Mol Genet Metab. 2017 Jun;121(2):162-169. doi: 10.1016/j.ymgme.2017.05.007. Epub 2017 May 13.
7
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria.足突消失是年轻的无蛋白尿经典法布里病患者肾病的早期标志物。
Nephron. 2015;129(1):16-21. doi: 10.1159/000369309. Epub 2014 Dec 17.
8
Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.两名迟发性法布里半合子患者的临床病程及病理结果,包括酶替代治疗后的桑葚细胞计数
CEN Case Rep. 2020 Aug;9(3):237-242. doi: 10.1007/s13730-020-00463-z. Epub 2020 Mar 18.
9
Biomarkers of Fabry disease nephropathy.法布里病肾病的生物标志物。
Clin J Am Soc Nephrol. 2010 Feb;5(2):360-4. doi: 10.2215/CJN.06090809. Epub 2009 Nov 5.
10
Glomerular Hyperfiltration: An Early Marker of Nephropathy in Fabry Disease.肾小球高滤过:法布瑞氏病肾病的早期标志物。
Nephron. 2019;141(1):10-17. doi: 10.1159/000493469. Epub 2018 Nov 22.

引用本文的文献

1
Fabry App: the value of a portable technology in recording day-to-day patient monitored information in patients with Fabry disease.法布瑞 APP:在记录法布瑞病患者日常监测信息方面,便携式技术的价值。
Orphanet J Rare Dis. 2024 Jan 11;19(1):13. doi: 10.1186/s13023-023-02999-6.
2
Concurrent fabry disease and immunoglobulin a nephropathy: a case report.同时患有法布里病和免疫球蛋白 A 肾病:一例报告。
BMC Nephrol. 2023 Nov 1;24(1):324. doi: 10.1186/s12882-023-03282-3.
3
The evolution of the initial manifestations and renal involvement of chinese patients with classical and late-onset Fabry disease at different sexes and ages.中国经典型和迟发性 Fabry 病患者不同性别和年龄的首发表现和肾脏受累的演变。
BMC Nephrol. 2023 Apr 5;24(1):90. doi: 10.1186/s12882-023-03138-w.
4
Clinical features and enzyme replacement therapy in 10 children with Fabry disease.10例法布里病患儿的临床特征及酶替代治疗
Front Pediatr. 2023 Feb 3;11:1084336. doi: 10.3389/fped.2023.1084336. eCollection 2023.
5
Clinical Characteristics, Renal Involvement, and Therapeutic Options of Pediatric Patients With Fabry Disease.法布里病患儿的临床特征、肾脏受累情况及治疗选择
Front Pediatr. 2022 Jun 1;10:908657. doi: 10.3389/fped.2022.908657. eCollection 2022.
6
Recommendations for the diagnosis and management of Fabry disease in pediatric patients: a document from the Rare Diseases Committee of the Brazilian Society of Nephrology (Comdora-SBN).儿童法布里病诊断与管理建议:巴西肾脏病学会罕见病委员会(Comdora-SBN)文件
J Bras Nefrol. 2022 Apr-Jun;44(2):268-280. doi: 10.1590/2175-8239-JBN-2021-0216.
7
Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective.专家意见:从多学科角度看待法布瑞病患儿和成人的识别、诊断和管理:土耳其的观点。
Orphanet J Rare Dis. 2022 Mar 2;17(1):90. doi: 10.1186/s13023-022-02215-x.
8
Fabry disease-what cardiologists can learn from the nephrologist: a narrative review.法布里病——心脏病专家能从肾病专家身上学到什么:一篇叙述性综述。
Cardiovasc Diagn Ther. 2021 Apr;11(2):672-682. doi: 10.21037/cdt-20-981.
9
Fabry disease and kidney involvement: starting from childhood to understand the future.法布里病与肾脏受累:从儿童期开始了解未来
Pediatr Nephrol. 2022 Jan;37(1):95-103. doi: 10.1007/s00467-021-05076-x. Epub 2021 Apr 30.
10
Interstitial lung disease in lysosomal storage disorders.溶酶体贮积症相关性间质性肺疾病。
Eur Respir Rev. 2021 Apr 29;30(160). doi: 10.1183/16000617.0363-2020. Print 2021 Jun 30.

本文引用的文献

1
Measurement and estimation of GFR in children and adolescents.儿童和青少年肾小球滤过率的测量和估计。
Clin J Am Soc Nephrol. 2009 Nov;4(11):1832-43. doi: 10.2215/CJN.01640309. Epub 2009 Oct 9.
2
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease.酶替代疗法治疗法布里病肾病的安全性和有效性。
Biologics. 2008 Dec;2(4):823-43. doi: 10.2147/btt.s3770.
3
Agalsidase alfa and kidney dysfunction in Fabry disease.阿加糖酶α与法布里病中的肾功能障碍
J Am Soc Nephrol. 2009 May;20(5):1132-9. doi: 10.1681/ASN.2008080870. Epub 2009 Apr 8.
4
Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy.法布里病:肾病进展以及酶替代治疗前心脏和脑血管事件的患病率。
Nephrol Dial Transplant. 2009 Jul;24(7):2102-11. doi: 10.1093/ndt/gfp031. Epub 2009 Feb 13.
5
The MDRD equation may mask decline of glomerular filtration rate in Fabry patients with normal or nearly normal kidney function.MDRD方程可能会掩盖法布里病患者肾小球滤过率的下降,这些患者的肾功能正常或接近正常。
Clin Nephrol. 2009 Feb;71(2):118-24. doi: 10.5414/cnp71118.
6
Prime time for enzymatic creatinine methods in pediatrics.儿科中酶法测定肌酐的最佳时机。
Clin Chem. 2009 Mar;55(3):549-58. doi: 10.1373/clinchem.2008.116863. Epub 2009 Jan 23.
7
New equations to estimate GFR in children with CKD.估算慢性肾脏病儿童肾小球滤过率的新方程。
J Am Soc Nephrol. 2009 Mar;20(3):629-37. doi: 10.1681/ASN.2008030287. Epub 2009 Jan 21.
8
Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry.法布里病注册研究中352例儿科患者的法布里病特征分析。
Pediatr Res. 2008 Nov;64(5):550-5. doi: 10.1203/PDR.0b013e318183f132.
9
How to estimate GFR in children.如何估算儿童的肾小球滤过率。
Nephrol Dial Transplant. 2009 Mar;24(3):714-6. doi: 10.1093/ndt/gfn306. Epub 2008 May 29.
10
Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria.患有法布里病且微量白蛋白尿的儿童和青少年的肾活检结果。
Am J Kidney Dis. 2008 May;51(5):767-76. doi: 10.1053/j.ajkd.2007.12.032. Epub 2008 Mar 20.

评估法布里病患儿的肾脏病理和功能障碍。

Assessment of renal pathology and dysfunction in children with Fabry disease.

机构信息

Paediatric Metabolic Unit, Addenbrooke's University Teaching Hospital, Cambridge, United Kingdom.

出版信息

Clin J Am Soc Nephrol. 2010 Feb;5(2):365-70. doi: 10.2215/CJN.08091109. Epub 2010 Jan 7.

DOI:10.2215/CJN.08091109
PMID:20056758
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4909119/
Abstract

Overt renal disease often first presents in male individuals with Fabry disease in early to middle adulthood, but proteinuria and reduced GFR may occur in adolescents and in young children. More recently, kidney biopsy data have shown early renal histologic changes in pediatric patients, and kidney dysfunction, primarily proteinuria, seems to be more common in girls. Renal investigations and their timing in children remain poorly defined. A consensus on renal investigations is necessary to understand the natural progression of the disease and to evaluate the efficacy of treatments such as enzyme replacement therapies. This article addresses three main categories: Use of GFRs, measuring albuminuria, and renal biopsies in children.

摘要

显性肾脏疾病通常首先出现在患有法布瑞病的男性个体中,发病年龄为成年早期到中期,但蛋白尿和肾小球滤过率降低也可能发生于青少年和幼儿中。最近,肾脏活检数据显示儿科患者存在早期肾脏组织学改变,且肾功能障碍,主要是蛋白尿,似乎在女孩中更为常见。儿童的肾脏检查及其时机仍未明确界定。有必要就肾脏检查达成共识,以了解疾病的自然进展,并评估酶替代疗法等治疗方法的疗效。本文主要探讨了三个方面:肾小球滤过率的应用、白蛋白尿的测量和儿童肾脏活检。